139 related articles for article (PubMed ID: 38737191)
1. Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.
Ohbayashi H; Ariga M; Ohta K; Kudo S; Furuta O; Yamamoto A
Int J Chron Obstruct Pulmon Dis; 2024; 19():995-1010. PubMed ID: 38737191
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
[No Abstract] [Full Text] [Related]
3. Analysis of the Effects of Ninjin'yoeito on Physical Frailty in Mice.
Otsuka S; Fukumaru K; Tani A; Takada S; Kikuchi K; Norimatsu K; Matsuzaki R; Matsuoka T; Sakakima H; Omiya Y; Mizuno K; Matsubara Y; Maruyama I
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232484
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of ninjin'yoeito to treat frailty in older adults: A case series.
Sakisaka N
Neuropeptides; 2022 Jun; 93():102244. PubMed ID: 35381491
[TBL] [Abstract][Full Text] [Related]
5. Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model.
Takemoto R; Sejima T; Han LK; Michihara S; Takahashi R
Neuropeptides; 2021 Dec; 90():102199. PubMed ID: 34610544
[TBL] [Abstract][Full Text] [Related]
6. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report.
Kuniaki H; Akihiko T; Tetsuya H; Hatsuko M; Tomoko K; Shin O; Sojiro K; Mayumi Y; Fumihiro Y; Shintaro S; Tsukasa O; Hironori S
Front Nutr; 2018; 5():71. PubMed ID: 30234120
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.
Kushima H; Kinoshita Y; Fujita M; Ishii H
Neuropeptides; 2021 Oct; 89():102178. PubMed ID: 34298370
[TBL] [Abstract][Full Text] [Related]
8. Ninjin'yoeito reduces fatigue-like conditions by alleviating inflammation of the brain and skeletal muscles in aging mice.
Otsuka S; Matsuzaki R; Kakimoto S; Tachibe Y; Kawatani T; Takada S; Tani A; Nakanishi K; Matsuoka T; Kato Y; Inadome M; Nojima N; Sakakima H; Mizuno K; Matsubara Y; Maruyama I
PLoS One; 2024; 19(5):e0303833. PubMed ID: 38768175
[TBL] [Abstract][Full Text] [Related]
9. Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients.
Suzuki S; Aihara F; Shibahara M; Sakai K
Front Nutr; 2019; 6():14. PubMed ID: 30873411
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
Zu Y; Li D; Lei X; Zhang H
Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the usefulness of Ninjin'yoeito Kampo medicine in combination with rehabilitation therapy in patients with frailty complicated by intractable dizziness.
Arai M
Neuropeptides; 2021 Dec; 90():102189. PubMed ID: 34481223
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty.
Kashima M
Front Nutr; 2021; 8():547512. PubMed ID: 33937301
[No Abstract] [Full Text] [Related]
13. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
Front Nutr; 2018; 5():126. PubMed ID: 30619872
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three frailty models and a sarcopenia model in elderly patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Kaneko K; Uno T; Sato H; Manabe R; Ohta S; Kusumoto S; Yamaguchi F; Suzuki S; Sagara H
Geriatr Gerontol Int; 2019 Sep; 19(9):896-901. PubMed ID: 31309700
[TBL] [Abstract][Full Text] [Related]
15. Frailty syndrome in ambulatory patients with COPD.
Limpawattana P; Putraveephong S; Inthasuwan P; Boonsawat W; Theerakulpisut D; Chindaprasirt J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1193-1198. PubMed ID: 28458530
[TBL] [Abstract][Full Text] [Related]
16. Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.
Miyamoto A; Asai K; Kadotani H; Maruyama N; Kubo H; Okamoto A; Sato K; Yamada K; Ijiri N; Watanabe T; Kawaguchi T
Int J Chron Obstruct Pulmon Dis; 2020; 15():3063-3077. PubMed ID: 33273811
[TBL] [Abstract][Full Text] [Related]
17. Impact of
Okada KI; Kawai M; Hirono S; Miyazawa M; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Shimokawa T; Yamaue H
Curr Ther Res Clin Exp; 2020; 93():100605. PubMed ID: 33014206
[TBL] [Abstract][Full Text] [Related]
18. Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.
Ito T; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Nakaya A; Satake A; Ishii K; Nomura S
Front Nutr; 2018; 5():72. PubMed ID: 30186837
[TBL] [Abstract][Full Text] [Related]
19. Body Composition of Filipino Chronic Obstructive Pulmonary Disease (COPD) Patients in Relation to Their Lung Function, Exercise Capacity and Quality of Life.
Chua JR; Albay AB; Tee ML
Int J Chron Obstruct Pulmon Dis; 2019; 14():2759-2765. PubMed ID: 31819408
[TBL] [Abstract][Full Text] [Related]
20. The Role of Muscle Mass Gain Following Protein Supplementation Plus Exercise Therapy in Older Adults with Sarcopenia and Frailty Risks: A Systematic Review and Meta-Regression Analysis of Randomized Trials.
Liao CD; Chen HC; Huang SW; Liou TH
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
